Skip to content

Clinical trials

Completed Attention Deficit Disorder with Hyperactivity trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Status: Completed Country / region: Sweden Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20071
20084
20091
20104
20114
20125
20132
20142
20153
20163
20181
20193
20201
20211
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet15
Shire9
Eli Lilly and Company3
Göteborg University2
Novartis Pharmaceuticals2
Region Skane2
Region Västmanland2
Uppsala University2
Halmstad University1
Janssen-Cilag International NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity42
Anxiety Disorders4
Autism Spectrum Disorder4
Neurodevelopmental Disorders2
Parasomnias2
Attention Deficit and Disruptive Behavior Disorders1
Autistic Disorder1
Oppositional Defiant Disorder1
Sleep Initiation and Maintenance Disorders1
Sleep Wake Disorders1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.